T Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 2010 Aug 5

PMID 20682002

Citations 431

Authors

J M Fletcher

S J Lalor

C M Sweeney

N Tubridy

K H G Mills

Affiliations

Soon will be listed here.

Abstract

Multiple sclerosis (MS) is a demyelinating inflammatory disorder of the central nervous system (CNS), which involves autoimmune responses to myelin antigens. Studies in experimental autoimmune encephalomyelitis (EAE), an animal model for MS, have provided convincing evidence that T cells specific for self-antigens mediate pathology in these diseases. Until recently, T helper type 1 (Th1) cells were thought to be the main effector T cells responsible for the autoimmune inflammation. However more recent studies have highlighted an important pathogenic role for CD4(+) T cells that secrete interleukin (IL)-17, termed Th17, but also IL-17-secreting γδ T cells in EAE as well as other autoimmune and chronic inflammatory conditions. This has prompted intensive study of the induction, function and regulation of IL-17-producing T cells in MS and EAE. In this paper, we review the contribution of Th1, Th17, γδ, CD8(+) and regulatory T cells as well as the possible development of new therapeutic approaches for MS based on manipulating these T cell subtypes.

Citing Articles

Akkermansia muciniphila Modulates Central Nervous System Autoimmune Response and Cognitive Impairment by Inhibiting Hippocampal NLRP3-Mediated Neuroinflammation.

Li X, Lin D, Hu X, Shi X, Huang W, Ouyang Y CNS Neurosci Ther. 2025; 31(3):e70320.

PMID: 40050112 PMC: 11884925. DOI: 10.1111/cns.70320.

Discovering root causal genes with high-throughput perturbations.

Strobl E, Gamazon E Elife. 2025; 13.

PMID: 40042510 PMC: 11882141. DOI: 10.7554/eLife.100949.

K27-linked RORγt ubiquitination by Nedd4 potentiates Th17-mediated autoimmunity.

Zeng Q, Guo H, Tang N, Renavikar P, Karandikar N, Lovett-Racke A J Biomed Sci. 2025; 32(1):26.

PMID: 39972304 PMC: 11841259. DOI: 10.1186/s12929-025-01120-2.

An immunoregulatory amphipathic peptide derived from Fasciola hepatica helminth defense molecule (FhHDM-1.C2) exhibits potent biotherapeutic activity in a murine model of multiple sclerosis.

Lalor R, Tanaka A, Shiels J, Dixit A, Hoadley S, Dufourd E FASEB J. 2025; 39(4):e70380.

PMID: 39950309 PMC: 11826375. DOI: 10.1096/fj.202400793RR.

Multiple Sclerosis: A Story of the Interaction Between Gut Microbiome and Components of the Immune System.

Mohsen E, Haffez H, Ahmed S, Hamed S, El-Mahdy T Mol Neurobiol. 2025; .

PMID: 39934561 DOI: 10.1007/s12035-025-04728-5.

References

Astier A, Meiffren G, Freeman S, Hafler D . Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J Clin Invest. 2006; 116(12):3252-7. PMC: 1635165. DOI: 10.1172/JCI29251. View

Olivares-Villagomez D, Wang Y, Lafaille J . Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J Exp Med. 1998; 188(10):1883-94. PMC: 2212402. DOI: 10.1084/jem.188.10.1883. View

Gyulveszi G, Haak S, Becher B . IL-23-driven encephalo-tropism and Th17 polarization during CNS-inflammation in vivo. Eur J Immunol. 2009; 39(7):1864-9. DOI: 10.1002/eji.200939305. View

Hofstetter H, Ibrahim S, Koczan D, Kruse N, Weishaupt A, Toyka K . Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell Immunol. 2006; 237(2):123-30. DOI: 10.1016/j.cellimm.2005.11.002. View

Panitch H, Hirsch R, Haley A, Johnson K . Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet. 1987; 1(8538):893-5. DOI: 10.1016/s0140-6736(87)92863-7. View

Durelli L, Conti L, Clerico M, Boselli D, Contessa G, Ripellino P . T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta. Ann Neurol. 2009; 65(5):499-509. DOI: 10.1002/ana.21652. View

Lockhart E, Green A, Flynn J . IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol. 2006; 177(7):4662-9. DOI: 10.4049/jimmunol.177.7.4662. View

Matusevicius D, Kivisakk P, He B, Kostulas N, Ozenci V, Fredrikson S . Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler. 1999; 5(2):101-4. DOI: 10.1177/135245859900500206. View

Coquet J, Chakravarti S, Smyth M, Godfrey D . Cutting edge: IL-21 is not essential for Th17 differentiation or experimental autoimmune encephalomyelitis. J Immunol. 2008; 180(11):7097-101. DOI: 10.4049/jimmunol.180.11.7097. View

10.

Lees J, Iwakura Y, Russell J . Host T cells are the main producers of IL-17 within the central nervous system during initiation of experimental autoimmune encephalomyelitis induced by adoptive transfer of Th1 cell lines. J Immunol. 2008; 180(12):8066-72. DOI: 10.4049/jimmunol.180.12.8066. View

11.

Cox A, Thompson S, Jones J, Robertson V, Hale G, Waldmann H . Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis. Eur J Immunol. 2005; 35(11):3332-42. DOI: 10.1002/eji.200535075. View

12.

Kumar M, Putzki N, Limmroth V, Remus R, Lindemann M, Knop D . CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis. J Neuroimmunol. 2006; 180(1-2):178-84. DOI: 10.1016/j.jneuroim.2006.08.003. View

13.

Kohm A, Carpentier P, Anger H, Miller S . Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J Immunol. 2002; 169(9):4712-6. DOI: 10.4049/jimmunol.169.9.4712. View

14.

Liu Y, Teige I, Birnir B, Issazadeh-Navikas S . Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nat Med. 2006; 12(5):518-25. DOI: 10.1038/nm1402. View

15.

Kebir H, Ifergan I, Ivan Alvarez J, Bernard M, Poirier J, Arbour N . Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis. Ann Neurol. 2009; 66(3):390-402. DOI: 10.1002/ana.21748. View

16.

Wilson N, Boniface K, Chan J, McKenzie B, Blumenschein W, Mattson J . Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol. 2007; 8(9):950-7. DOI: 10.1038/ni1497. View

17.

Ponomarev E, Dittel B . Gamma delta T cells regulate the extent and duration of inflammation in the central nervous system by a Fas ligand-dependent mechanism. J Immunol. 2005; 174(8):4678-87. DOI: 10.4049/jimmunol.174.8.4678. View

18.

Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H . Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med. 2002; 8(5):500-8. DOI: 10.1038/nm0502-500. View

19.

Hong J, Li N, Zhang X, Zheng B, Zhang J . Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3. Proc Natl Acad Sci U S A. 2005; 102(18):6449-54. PMC: 1088385. DOI: 10.1073/pnas.0502187102. View

20.

Martinez-Forero I, Garcia-Munoz R, Martinez-Pasamar S, Inoges S, Lopez-Diaz de Cerio A, Palacios R . IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis. Eur J Immunol. 2008; 38(2):576-86. DOI: 10.1002/eji.200737271. View